Last reviewed · How we verify
NCT03358745
Impact of Meal Order on Postprandial Cardiometabolic Risk Markers
NA trial testing Standard meal, bread/butter as starter in Metabolic Syndrome X in 21 participants. Completed in 1 December 2018.
31 March 2018
Quick facts
| Lead sponsor | Lund University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 21 |
| Start date | 1 June 2016 |
| Primary completion | 31 March 2018 |
| Estimated completion | 1 December 2018 |
| Sites | 2 locations across Sweden |
Drugs / interventions tested
- Standard meal, bread/butter as starter
- Standard meal with soup as starter
- Standard meal with cheese as starter
- Standard meal with salad as starter
Conditions studied
- Metabolic Syndrome X — all drugs for Metabolic Syndrome X →
- Insulin Resistance — all drugs for Insulin Resistance →
- Hyperinsulinism — all drugs for Hyperinsulinism →
- Glucose Metabolism Disorders — all drugs for Glucose Metabolism Disorders →
Sponsor
Lund University
Who can join
Adults 20 to 70, any sex, with Metabolic Syndrome X or Insulin Resistance. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The order in which the different components of a meal are eaten may have impact on the postprandial metabolic responses to carbohydrates, fat and proteins. This study will compare blood lipids and glycemia regulation following lunches of identical composition but varying the order of intake of the different meal components.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03358745
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Metabolic Syndrome X
Currently open trials in the same condition.
- NCT06661655 — Evaluation of a New Ultrasound System for the Non-invasive Assessment of Liver Steatosis in MASLD/MASH Patients · NA · recruiting
- NCT06394934 — Home Blood Pressure Variability and Its Link to Arteriosclerosis and Metabolic Dysfunction in Hypertensive Patients · recruiting
- NCT06702085 — Lifestyle Changes in Older Adults With Metabolic Syndrome and Tinnitus · NA · recruiting
- NCT06650943 — Nursing Intervention in Weight and Metabolic Syndrome Management in First-episode Psychosis (MetaKOP) · NA · recruiting
Other Lund University trials
Trials by the same sponsor.
- NCT06661460 — Internet-Delivered Cognitive Behavioral Intervention for Youths With Anxiety Disorders · NA · recruiting
- NCT07425925 — Digital Peer-support-based Anti-HIV Stigma Intervention Among Adolescents Living With HIV in Ethiopia · NA · recruiting
- NCT07407842 — UPSIDES - Recovery Through Peer Support · NA · enrolling by invitation
- NCT07141108 — Self-monitoring and Remote Monitoring of Chronic Pain in Primary Care - Using a Digital Tool to Improve Quality of Life · NA · recruiting
- NCT07025694 — Exercise Training Among Children With Cerebral Palsy to Increase Health and Well-being - A Feasibility Study · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03358745 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Lund University
- Last refreshed: 9 May 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03358745.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing